focus -WSS

focus

author：Wikipedia 2025-09-06 03:58:25 - browse：42

Eli Lilly said Friday it will acquire Versanis Bio, a private company developing an obesity drug that specifically targets fat mass, as the race among pharmaceutical companies to offer weight loss medications intensifies.

The deal indicates Lilly is aiming to diversify its growing portfolio of weight loss therapies, as Versanis’ drug employs an entirely different mechanism than the existing obesity drugs that Lilly is studying. The pharma giant didn’t say how much it would pay Versanis upfront, but said that if the drug meets certain milestones, the total payment could reach $1.9 billion.

Lilly, along with other pharma companies like Novo Nordisk, has been developing products in the class of GLP-1 drugs, which mimic the glucagon-like peptide 1 hormone that helps people feel full. These drugs – including Novo’s Ozempic and Wegovy, and Lilly’s Mounjaro – have exploded in popularity because they lead to significant weight loss.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： HHS suspends federal funding for EcoHealth Alliance

hotspot

knowledge

WSS

Elizabeth Warren probes abortion access

In new study, freeze

Review: 'Barbie' will hit you like a shot in the heart

Readout Newsletter: Raw milk, Wegovy tests, Eisai and Biogen

WuXi Biologics beefs up its lobbying operation

Artificial intelligence advances fuel industry trying to preserve loved ones after death

hotspot

focus

entertainment

Medicare details structure of new drug price negotiation program

Vatican is moving ahead with plan to reunite Ukrainian children taken to Russia with their families

Cancer drug shortages should be causing more outrage

Death toll from an explosion and collapse of a Paris building in June climbs to 3

Alkermes shareholders re

WuXi Biologics execs register to lobby as Congress comes for the company

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Galapagos to make CAR

Supreme Court strikes down use of affirmative action

CVS is willing to dump 10% of its Medicare Advantage members

hotspot

To spot an incipient stroke, tiny brain probe acts ‘like a microscope’

Hyaluronic acid injections don’t help knee osteoarthritis, study finds

Boston hospital trains restaurant workers on naloxone for overdoses

Why an extreme heat and wildfire smoke combination can be so dangerous

Readout Newsletter: Raw milk, Wegovy tests, Eisai and Biogen

Raw milk easy to obtain despite bird flu warning, FDA interstate ban

hotspot

knowledge

explore

entertainment